Filtered news list testing
List of Reports
.pdf
11/19/2025 - Financial agenda 2026
.pdf
10/23/2025 - Revenue at September 30, 2025
.pdf
Qitexio and LUF legal mentions 2025
.pdf
09/25/2025 - Half-year financial report 2025
.pdf
09/25/2025 - 2025 Half-year results (Presentation)
.pdf
09/24/2025 - H1 2025 results
.pdf
09/22/2025 - Change in General Management
.pdf
09/22/2025 - Change in General Management
Single report testing
.pdf
test report fabien V 09-07
Separator
Discover the latest news of Guerbet
Latest news
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT
U.S. Food and Drug Administration (FDA) grants Breakthrough Device status to the Guerbet innovation: LIPIOJOINT
2024 revenue
2024 revenue
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging
Guerbet, Intrasense, Gustave Roussy and the University Hospital of Angers receive a €5.9M financing from Bpifrance for Liflow®, innovative solution dedicated to oncology imaging